Laura Sanz

15PUBLICATIONS
90CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 28, 2026
GPA33-Targeted Trimeric Immunotoxin Exhibits Enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.

Javier Ruiz-de-la-Herrán, Javier Narbona, Rubén G Gordo

|Apr 16, 2024
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.

Antonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Oct 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.

Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo

|Jul 29, 2023
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.

Javier Narbona, Luisa Hernández-Baraza, Rubén G Gordo

|Apr 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood

Pageof 3

Frequent Collaborators

9 joint publications

Luis Alvarez-Vallina

7 joint publications

Marta Compte

6 joint publications

Francisco J Blanco

4 joint publications

Antonio Tapia-Galisteo